BioRestorative Therapies's three largest insider shareholders as of September 29, 2026 are Dale Broadrick (TenPercentOwner, 0 shares), Dale Broadrick (TenPercentOwner, 0 shares), Francisco Silva (Vp Of Research And Development, 0 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dale Broadrick | TenPercentOwner | 0 | 0 | 0 | 100.0% | 04 Nov, 2024 |
| 2 | Francisco Silva | Vp Of Research And Development | 0 | 0 | 0 | 0.0% | 17 Oct, 2025 |
| 3 | Lance Alstodt | President, Ceo, Cob | 0 | 0 | 0 | 0.0% | 17 Oct, 2025 |
| 4 | Robert Eugene Kristal | Chief Financial Officer | 0 | 0 | 0 | 0.0% | 15 Jun, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $128,000,000.00 | $1.50Tn | 0 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 15,625 | $128,000,000.00 | $2.00Tn | 0 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 11,719 | $0.00 | $0 | 0 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | Nickolay V. Kukekov | Director | Acquired A | 52,632 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | Patrick F. Williams | Director | Acquired A | 52,632 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | David A Rosa | Director | Acquired A | 52,632 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | Robert Eugene Kristal | Chief Financial Officer | Acquired A | 166,492 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 791,885 | $0.00 | $0 | 0 | Direct |
| 14 Feb, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 768,979 | $0.00 | $0 | 0 | Direct |
| 28 Oct, 2024 | Dale Broadrick | TenPercentOwner | Disposed S | 1,112 | $126,400,000.00 | $140.56Bn | 0 | Direct |
| 08 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 476 | $90,400,000.00 | $43.03Bn | 0 | Direct |
| 08 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 1,232 | $93,600,000.00 | $115.32Bn | 0 | Direct |
| 09 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 6,600 | $100,000,000.00 | $660.00Bn | 0 | Direct |
| 18 Mar, 2024 | Lance Alstodt | President, Ceo, Cob | Disposed F | 17,633 | $111,200,000.00 | $1.96Tn | 0 | Direct |
| 18 Mar, 2024 | Francisco Silva | Vp Of Research And Development | Disposed F | 17,193 | $111,200,000.00 | $1.91Tn | 0 | Direct |
| 13 Feb, 2024 | David A Rosa | Director | Acquired A | 79,646 | $0.00 | $0 | 0 | Direct |
| 13 Feb, 2024 | Nickolay V. Kukekov | Director | Acquired A | 79,646 | $0.00 | $0 | 0 | Direct |
| 13 Feb, 2024 | Robert Paccasassi | Vp, Qa And Reg Compliance | Acquired A | 219,298 | $0.00 | $0 | 0 | Direct |
| 13 Feb, 2024 | Patrick F. Williams | Director | Acquired A | 79,646 | $0.00 | $0 | 0 | Direct |